Long-term safety and efficacy of oral phentolamine mesylate (Vasomax®) in men with mild to moderate erectile dysfunction
Padma-Nathan, H, Goldstein, I, Klimberg, I, Coogan, C, Auerbach, S, Lammers, P, Gleason, D, Young, J, Kaufman, J, Gittelman, M, Knoll, D, Wiatrak, M, Wells, G, Brito, G, Steidle, C, Susset, J, Talley, D, Feldman, R, Murdock, M, Childs, S, Zinner, N, Dula, E, Koukol, S, Knapp, P, Immergut, M, Snyder, J, Kornitzer, G, Belker, A, Barada, J, Byrne, J, Harris, R, McMahon, G, Mobley, D, Bloom, S, Kidd, D, Tomera, K & Lamm, S 2002, International Journal of Impotence Research, vol 14, no. 4, pp. 266-270. DOI:
The long-term effect of specific type II 5a-reductase inhibition with finasteride on bone mineral density in men: Results of a 4-year placebo controlled trial
Matsumoto, AM, Tenover, L, McClung, M, Mobley, D, Geller, J, Sullivan, M, Grayhack, J, Wessells, H, Kadmon, D, Flanagan, M, Zhang, GK, Schmidt, J, Taylor, AM, Lee, M & Waldstreicher, J 2002, Journal of Urology, vol 167, no. 5, pp. 2105-2108.
Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia
Kaplan, SA, Holtgrewe, HL, Bruskewitz, R, Saltzman, B, Mobley, D, Narayan, P, Lund, RH, Weiner, S, Wells, G, Cook, TJ, Meehan, A & Waldstreicher, J 2001, Urology, vol 57, no. 6, pp. 1073-1077. DOI:
Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence
Versi, E, Appell, R, Mobley, D, Patton, W & Saltzstein, D 2000, Obstetrics and Gynecology, vol 95, no. 5, pp. 718-721. DOI:
Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence
Anderson, RU, Mobley, D, Blank, B, Saltzstein, D, Susset, J & Brown, JS 1999, Journal of Urology, vol 161, no. 6, pp. 1809-1812. DOI:
Effects of doxazosin in patients with mild, intermediate, and severe benign prostatic hyperplasia
Mobley, DF, Dias, N & Levenstein, M 1998, Clinical Therapeutics, vol 20, no. 1, pp. 101-109. DOI:
Effect of doxazosin on the symptoms of benign prostatic hyperplasia: Results from three double-blind placebo-controlled studies
Mobley, DF, Kaplan, S, Ice, K, Gaffney, M & Dias, N 1997, International Journal of Clinical Practice, vol 51, no. 5, pp. 282-288.
Doxazosin for benign prostatic hyperplasia: Long-term efficacy and safety in hypertensive and normotensive patients
Lepor, H, Kaplan, SA, Klimberg, I, Mobley, DF, Fawzy, A, Gaffney, M, Ice, K & Dias, N 1997, Journal of Urology, vol 157, no. 2, pp. 525-530. DOI:
The Effect of Zanoterone, a Steroidal Androgen Receptor Antagonist, in Men with Benign Prostatic Hyperplasia
Berger, BM, Naadimuthu, A, Boddy, A, Fisher, HA, McConnell, JD, Milam, D, Mobley, D & Rajfer, JFTZSG 1995, The Journal of Urology, vol 154, no. 3, pp. 1060-1064.
Clinical experience with mentor alpha I inflatable penile prosthesis. Report on 333 cases
Randrup, E, Wilson, S, Mobley, D, Suarez, G, Mekras, G & Baum, N 1993, Urology, vol 42, no. 3, pp. 305-308.